Abstract
Despite the relative low incidence, when compared to other lung tumors, Small cell lung carcinoma (SCLC) is the most aggressive subtype, with high capacity of growth and dissemination. About 30% of patients diagnosed with SCLC do not respond to first line chemotherapy and relapse within 6 months. Mechanisms of tumor escape are still unknown, however they can involve: i) rapid evolution an…